Related Experiment Videos
[Clinical analysis of CAPD-treated patients without anemia]
Maria Majdan1, Agnieszka M Grzebalska, Piotr Mierzicki
1Katedry i Kliniki Nefrologii Akademii Medycznej w Lublinie.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|August 7, 2003
Summary
Some patients with chronic renal failure (CRF) undergoing continuous ambulatory peritoneal dialysis (CAPD) can achieve higher hemoglobin levels without erythropoietin treatment. This suggests non-erythropoietin factors regulate red blood cell production in these individuals.
Area of Science:
- Nephrology
- Hematology
- Internal Medicine
Background:
- Chronic renal failure (CRF) often leads to anemia, requiring treatment like recombinant human erythropoietin (rHuEpo).
- Maintaining adequate hemoglobin levels (>12 g/dl) without rHuEpo is uncommon in CRF patients.
Purpose of the Study:
- To analyze clinical characteristics of CRF patients on CAPD who maintain normal hemoglobin levels without rHuEpo treatment.
- To investigate factors contributing to spontaneous erythropoiesis in this patient group.
Main Methods:
- Clinical analysis of 12 CAPD patients with hemoglobin >12 g/dl for at least 6 months, without rHuEpo.
- Assessment of hemoglobin, hematocrit, C-reactive protein, ferritin, and endogenous erythropoietin (Epo) levels.
- Ultrasonographic investigation for acquired cystic kidney disease.
Main Results:
- 17.6% of 68 CAPD patients (12 individuals) maintained Hb >12 g/dl and Hct >35% without rHuEpo.
- Mean Hb was 13.5 g/dl; no patients had acquired cystic kidney disease.
- Lower C-reactive protein and ferritin levels were observed compared to other CAPD patients.
- Mean endogenous Epo concentration was not significantly different from other CAPD patients.
Conclusions:
- Spontaneous increase in hemoglobin in CAPD patients is not linked to elevated endogenous Epo levels.
- Factors beyond Epo likely regulate erythropoiesis in CAPD patients with normal hemoglobin.
- Further research is needed to identify these non-Epo regulatory factors.